文献速递多重用药老年慢病共病管理衰弱、肌少症与跌倒

处方级联:我们只看到我们寻找的,我们只寻找我们知道的

Prescribing cascades: we see only what we look for, we look for only what we know.
PubMed 文献 · Age Ageing · 2022-01-01

本文指出,大多数药物由未接受老年医学专科培训的处方者启动和继续,可能无法识别药物诱发的疾病,需要新的检测和管理方法,并强调在药物审查中整合明确的级联标准。

要点

  • 处方级联在共病多药老年人中更常见,可表现为跌倒、头晕、新发尿失禁等非特异性症状。
  • 多数处方者未接受老年医学培训,可能无法识别药物诱发的疾病。
  • 需在药物审查中整合明确的处方级联标准以促进快速检测和纠正。

核心结论

  • 处方级联是老年人不适当处方的一个方面,需要新的检测和管理方法。
  • 在常规药物审查中检测和纠正处方级联,对级联的认识至关重要。
  • 明确的级联标准应与其他明确的不适当处方标准整合。

研究设计与样本

  • 本文为述评,未报告系统检索范围或样本量。

主要发现

  • 处方级联在共病和多药治疗的老年人中更易发生,多种药物可诱导各种副作用,表现为非特异性症状,可能被误认为新的老年综合征如跌倒、头晕和新发尿失禁。
  • 老年医学医生经常遇到药物副作用,通常会考虑新症状的老年患者是否可能经历药物不良反应或事件。
  • 大多数给共病老年患者处方的药物由未接受老年医学专科培训的处方者启动和继续,他们可能无法检测药物诱发的疾病。
  • 目前关于老年人处方级联的知识库正朝着更好的级联检测和二级预防方法发展。
  • 文献中描述的级联数量众多、级联症状范围广泛以及处于风险中的共病老年人数量迅速增加,给处方者带来重大挑战。

临床怎么用

  • 在共病老年人的常规药物审查中,应提高对处方级联的认识以检测和纠正级联。
  • 需要新的明确定义级联的方式,以促进药物审查中的快速检测和纠正。
  • 明确的级联标准应与其他明确的不适当处方标准整合。

局限性

  • 缺乏老年人处方级联的前瞻性患病率研究。
  • 文献中描述的级联数量众多、症状范围广泛,给处方者带来挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prescribing cascades are increasingly recognized since they were described in the mid-1990s. Cascades are more likely in older people with multimorbidity and associated polypharmacy where multiple medications can induce a variety of side effects that manifest with various non-specific symptoms that may be misidentified as new geriatric syndromes such as falls, dizziness and new-onset incontinence. Geriatricians encounter medication side effects frequently and will usually consider if an older patient presenting with new symptoms could be experiencing an adverse drug reaction or event. However, most medications prescribed to multimorbid older patients are initiated and continued by prescribers without specialist geriatric training who may not detect medication-induced morbidity. Therefore, novel approaches to the detection and management of prescribing cascades in older people are needed. Currently, the knowledge base surrounding prescribing cascades in older people is evolving towards better methods for cascade detection and secondary prevention. However, the large number of cascades described in the literature, the wide-ranging symptomatology of cascades and the rapidly increasing number of multimorbid older people at risk of cascades represent major challenges for prescribers. Furthermore, prospective prevalence studies of prescribing cascades in older people are lacking. To detect and correct prescribing cascades during routine medication review in multimorbid older people, awareness of cascades is essential. Prescribing cascade awareness in turn requires novel explicit ways of defining cascades to facilitate their rapid detection and correction during medication review. Given that prescribing cascades represent another aspect of inappropriate prescribing (IP), explicit cascades criteria should be integrated with other explicit IP criteria.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. O'Mahony D, Rochon PA. Prescribing cascades: we see only what we look for, we look for only what we know. Age Ageing. 2022. PMID: 35776668. doi:10.1093/ageing/afac138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。